Community Center

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient…

As disease-modifying therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) continue to advance, accurately tracking disease progression is essential.This…

Has anyone here first suspected of Al Amyloidosis by MGUS with low antibodies numbers.

Join us at  for a specialized scientific meeting focused on the latest updates in the diagnosis and management of Cardiac Amyloidosis.15 May 2026Crowne Plaza…

Brief SummaryCardiac amyloidosis is a progressive disorder caused by extracellular deposition of amyloid fibrils in the heart, leading to heart failure and impaired…

New #CardioOnc Webinar | 'Novel Therapies in AL Amyloidosis', this Thursday https://www.radcliffecardiology.com/.../novel-therapies...Don’t miss out on this in…

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a progressive, life-threatening condition that is notoriously difficult to diagnose. Often mistaken for more…

As #HeartFailure26 begins, perspectives from across the field are shaping how we think about transthyretin #amyloidosis with cardiomyopathy (ATTR-CM). Dr.…

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a progressive, life-threatening condition that is notoriously difficult to diagnose. Often mistaken for more…

Cardiac Amyloidosis is a rare but serious condition where abnormal proteins called "Amyloid" accumulate in the heart muscle. This buildup causes the heart walls to…